Release date: February 2009
Expiration date: February 28, 2010
Estimated time to complete activity: 30 minutes
Sponsored by Curatio CME Institute
Support for this activity has been provided through an educational grant from Genentech, Inc.
Activity Overview
The year 2008 has seen significant advances in the development and use of biologic agents for the treatment of psoriasis. New drugs have been approved, clinical trial data on emerging agents have become available, and safety updates on existing agents have been reported. For this Expert Practice article, we interviewed Craig Leonardi, MD, Clinical Assistant Professor of Dermatology at St. Louis University, to help put the year's events into perspective and to review how these changes may affect the practicing dermatologist and ultimately improve the care provided to patients with psoriasis.
Target Audience
This activity has been designed to meet the educational needs of dermatologists and other health care professionals involved in the care of patients with psoriasis.
Learning Objectives
Upon completion of this activity, participants should be able to: - Recognize agents recently approved for the treatment of chronic moderate to severe plaque psoriasis
- Identify long-term safety issues associated with biologics used to treat psoriasis
- Review data for biologic agents in development to treat psoriasis
- Summarize developments in the use of biologic agents for psoriasis
Faculty
Craig L. Leonardi, MD
Associate Clinical Professor of Dermatology
Saint Louis University Medical School and Central Dermatology
St. Louis, Missouri
Accreditation Statement
Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Curatio CME Institute designates this educational activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period February 2009 to February 28, 2010, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form, including the certificate information section.
Media
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.
Disclosure
In accordance with the ACCME's Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:
Craig L. Leonardi, MD, has disclosed the following relevant financial relationships:
| Speaker: | Amgen | | Speaker and Consultant: | Abbott, Amgen, Centocor, Genentech, Inc. |
Dr. Leonardi discusses the unlabeled or investigational use of a commercial product.
Curatio CME Institute
Shari J. Dermer, PhD, Medical Director, has disclosed no relevant financial relationships.
Adam J. Perahia, MD, Medical Writer, has disclosed no relevant financial relationships.
Barbara Bekiesz, Editor, has disclosed no relevant financial relationships.
Derek Warnick, CME Director, has disclosed no relevant financial relationships.
Disclaimer
The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient's medical condition.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute and Genentech, Inc., do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute or Genentech, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Hardware/Software Requirements - Version 5.0 or higher for Microsoft Internet Explorer or Netscape 6 or higher
- If you are using a Mac computer system and are experiencing problems with your browser, we suggest downloading the latest version of Firefox for Mac
Contact Information
PsoriasisTx
100 Campbell Boulevard
Suite 103
Exton, PA 19341
editor@psoriasistx.com
Policy on Privacy and Confidentiality
Curatio CME Institute makes every effort to protect the privacy of PsoriasisTx.com users; user information is used only to maintain records as required by the American Medical Association (AMA) and the Accreditation Council for Continuing Medical Education (ACCME).
Curatio CME Institute does not require individuals to register to use PsoriasisTx.com; registration is only required for physicians, health care professionals, and other users to participate in and receive CME/CE credit for accredited educational programs hosted on PsoriasisTx.com
Curatio CME Institute is required by the AMA and the ACCME (and occasionally by other accrediting organizations) to collect user information that will allow Curatio CME Institute to issue a CME/CE certificate. Curatio CME Institute is required to keep this information on file for up to 6 years. The information is stored in a secure database and used only to verify individual participation in a CME/CE activity and to reissue a certificate if a user’s original certificate is lost or misplaced.
Information gathered through PsoriasisTx.com will not be released to any other company or organization for any purpose; this information remains confidential. At the end of the mandatory 6-year period, these records will be destroyed.
Curatio CME Institute uses Web site tracking software to determine how PsoriasisTx.com is used. This information helps Curatio determine the best strategies for improving PsoriasisTx.com and better meeting the needs of its users. This software does not identify individual users.
PsoriasisTx.com does not employ cookies or any other software that violates a user's privacy.
If you have any questions about PsoriasisTx.com or any Curatio CME Institute policies, you may contact us at editor@psoriasistx.com.
Thank you for using PsoriasisTx.com.
|
 |
 |
REGISTER NOW
